Core Insights - The information technology sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, with a value below 30 indicating potential buying opportunities [1] Company Summaries - **Accenture Plc (ACN)**: - Recently acquired IAMConcepts, a Canadian IAM services company - Stock has decreased approximately 26% over the past six months, with a 52-week low of $236.67 - Current RSI value is 28, and shares closed at $243.11 after a 3.5% drop [7] - **C3.ai Inc (AI)**: - Missed first-quarter earnings estimates and provided weak guidance - Stock fell around 5% in the past month, with a 52-week low of $14.70 - Current RSI value is 28, and shares closed at $15.61 after a 0.8% decline [7] - **Endava PLC (DAVA)**: - Reported mixed quarterly results, with a focus on AI integration in projects - Stock has decreased approximately 24% over the past month, with a 52-week low of $9.36 - Current RSI value is 25.7, and shares closed at $9.40 after a 5.3% drop [7]

Core Insights - The information technology sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, with a value below 30 indicating that a stock may be oversold [1] Company Summaries - **Accenture Plc (ACN)**: - Recently acquired IAMConcepts, a Canadian company specializing in identity and access management services - Stock has fallen approximately 26% over the past six months, with a 52-week low of $236.67 - Current RSI value is 28, and shares closed at $243.11 after a 3.5% decline [7] - **C3.ai Inc (AI)**: - Missed first-quarter earnings estimates and provided weak guidance - Stock has decreased around 5% over the past month, with a 52-week low of $14.70 - Current RSI value is 28, and shares closed at $15.61 after a 0.8% decline [7] - **Endava PLC (DAVA)**: - Reported mixed quarterly results, with a focus on AI integration among clients - Stock has dropped approximately 24% over the past month, with a 52-week low of $9.36 - Current RSI value is 25.7, and shares closed at $9.40 after a 5.3% decline [7]

Core Insights - C3.ai, Inc. has launched a new product called C3 AI Agentic Process Automation, which utilizes autonomous AI agents to manage business and operational workflows across enterprises [1][4] - The new product is designed to handle various business processes, including order-to-cash, customer service, invoice processing, debt collection, supplier onboarding, procurement, employee onboarding, industrial operations, manufacturing operations, production planning, inventory management, and aircraft maintenance [2] - By replacing traditional robotic process automation tools with AI models, the C3 AI Agentic Process Automation enhances enterprises' capabilities by integrating reasoning capabilities of modern AI with pre-determined steps and controls [3] Company Overview - C3.ai, Inc. is an enterprise artificial intelligence software company focused on building and operating enterprise-scale AI applications and facilitating digital transformation [4] - The CEO of C3 AI, Stephen Ehikian, emphasized that the C3 AI Agentic Process Automation represents a significant shift in the nature of work, enabling customers to efficiently manage complex workflows from start to finish [4]

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance [3][4]. Summary by Relevant Sections Allegations - The complaint claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth, particularly the CEO's health affecting deal closures [3]. - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [3]. Stock Price Impact - Following the announcement on August 8, 2025, C3.ai's stock price dropped from $22.13 per share to $16.47 per share by August 11, 2025, marking a decline of approximately 25.58% in just one day [3]. Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates throughout the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5].

Core Insights - C3.ai, Inc. has experienced a significant decline in stock price, dropping 36.2% over the past three months, compared to an 8.5% decline in the industry and a 9% increase in the S&P 500 [1][5][6] - The company's shares closed at $15.74, just above its 52-week low of $14.70, indicating a challenging market position [1][5] - C3.ai's recent quarterly performance revealed a nearly 20% year-over-year revenue decline, with sales missing expectations and widening losses at both operating and net levels [5][9] Financial Performance - The company reported a gross margin of 52%, which is below investor expectations, and has withdrawn its full-year guidance, indicating management's uncertainty about future performance [6][8][9] - The Zacks Consensus Estimate for fiscal 2026 and 2027 loss per share has widened, with current estimates showing a loss of $1.37 for the current year and $0.60 for the next year [14][15] - The estimated sales for fiscal 2026 imply a year-over-year decline of 5.6%, while growth of 15.2% is expected for fiscal 2027 [15] Operational Challenges - Poor sales execution has been identified as a major factor behind the weak quarterly performance, exacerbated by leadership changes and restructuring within the sales and service teams [6][9] - The company has relied heavily on initial production deployments, which have higher upfront costs and limited immediate revenues, negatively impacting scale efficiencies [7][9] - Leadership transitions, including the founder stepping back and a new CEO being appointed, introduce additional risks during a critical period of execution challenges [9] Market Opportunities - Despite recent challenges, C3.ai highlights strong long-term opportunities, including an expanding customer base across various industries such as manufacturing and defense [10][11] - The company has secured partnerships with large enterprises, indicating ongoing demand for its technology [10][11] - C3.ai's extensive product portfolio and new Strategic Integrator Program position it to capture a larger share of the estimated $2 trillion addressable market in enterprise AI [13] Valuation - C3.ai is currently priced at a discount relative to its industry, with a forward 12-month price-to-sales ratio of 5.46, significantly lower than peers like Palantir Technologies and Snowflake [16]

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. on behalf of investors who purchased shares during the specified class period, following the company's disappointing financial disclosures and leadership issues [1][3]. Group 1: Class Action Lawsuit - The lawsuit is initiated by Berger Montague PC for investors who acquired C3.ai shares from February 26, 2025, to August 8, 2025 [1][2]. - Investors have until October 21, 2025, to seek appointment as lead plaintiff representative of the class [2]. Group 2: Financial Performance - On August 8, 2025, C3.ai reported weak preliminary financial results for Q1 FY2026 and lowered its full-year revenue guidance, citing leadership changes and the CEO's health as contributing factors [3]. - Following the announcement, C3.ai's stock price fell from $22.13 to $16.47, marking a one-day loss of over 25% [3]. Group 3: Company Overview - C3.ai is based in Redwood City, California, and specializes in delivering scalable enterprise AI applications for various sectors, including commercial, industrial, and government [2].

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. due to allegations of misleading investors regarding the impact of the CEO's health on the company's business prospects, leading to a significant drop in stock price following disappointing financial results [2][3]. Group 1: Allegations and Impact - The lawsuit claims that C3.ai failed to disclose how the CEO's health affected the company's ability to close deals and that management was ineffective in mitigating this impact [2]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health problems [2]. - Following this announcement, C3.ai's stock price fell from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of over 25% [2]. Group 2: Legal Proceedings - Shareholders wishing to serve as lead plaintiff in the class action must submit their papers to the court by October 21, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3]. Group 3: Company Background - Robbins LLP is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses and improve corporate governance since 2002 [4].

Core Viewpoint - A class action lawsuit has been filed against C3.ai, alleging that the company and its executives misled investors regarding its financial health and growth prospects, violating the Securities Exchange Act of 1934 [1][2]. Summary by Sections Lawsuit Details - The lawsuit, titled Liggett v. C3.ai, Inc., claims that C3.ai provided overly optimistic revenue projections while downplaying risks associated with CEO Thomas M. Siebel's health issues [2]. - The lawsuit seeks to represent investors who purchased C3.ai securities between February 26, 2025, and August 8, 2025, with a lead plaintiff deadline set for October 21, 2025 [4]. Financial Performance - C3.ai's stock price dropped by over 25% following the company's financial announcement on August 8, 2025, which revealed preliminary first-quarter results that fell short of expectations and a lowered revenue guidance for the fiscal year [3]. - The disappointing results were attributed to "reorganization with new leadership" and Siebel's health problems [3]. Investigation Focus - The investigation is centered on whether C3.ai's public statements were misleading, particularly regarding the impact of CEO Siebel's health on the company's ability to meet financial targets [5].

Core Viewpoint - Law Offices of Frank R. Cruz is encouraging investors of C3.ai, Inc. to inquire about a potential securities fraud class action lawsuit against the company [1] Group 1 - The law firm is focusing on potential securities fraud claims related to C3.ai, Inc. [1] - Investors are being urged to seek more information regarding their rights and possible legal actions [1] - The announcement indicates a growing concern among investors about the company's practices [1]

Core Viewpoint - A class action lawsuit has been filed on behalf of investors who purchased C3.ai, Inc. securities during the specified class period, indicating potential legal challenges for the company [1] Group 1 - The lawsuit is on behalf of investors who bought C3.ai securities between February 26, 2025, and August 8, 2025 [1] - Investors have until October 21, 2025, to file a lead plaintiff motion [1] - The law offices of Howard G. Smith are representing the investors in this class action [1]